Ensysce Biosciences, Inc. ENSC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

Ensysce Biosciences, Inc. (ENSC) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は HG Vora Capital Management, LLC 3,837,500 株保有. その他の主要保有者には Silvers Daniel B. および GOWER BOB G.

ENSC インサイダー保有状況

最大保有者

HG Vora Capital Management, LLC

3,837,500 株

買い（12ヶ月）

$0.00 評価額

売り（12ヶ月）

$0.00 評価額

インサイダー上位保有者

#	氏名	役職	保有株数	最終申告日	相対規模
1	Hg Vora Capital Management, Llc	10 Percent Owner	3,837,500	2018-01-17	100%
2	Silvers Daniel B.	10 Percent Owner	1,637,390	2021-07-01	43%
3	Gower Bob G	Director	1,222,682	2023-03-06	32%
4	Kirkpatrick Lynn	Chief Executive Officer	381,851	2022-05-27	10%
5	Pestano Linda	Chief Development Officer	200,000	2022-02-04	5%
6	Weil A Lorne	10 Percent Owner	137,895	2021-07-01	4%
7	Benton Andrew	Director	100,850	2022-06-27	3%
8	Martin Steven Robert	Director	100,850	2022-06-27	3%
9	Humphrey David Carl	Chief Financial Officer	80,000	2022-02-24	2%
10	Schmidt William K	Chief Medical Officer	69,142	2021-07-02	2%
11	Birkett Kevin Geoffrey	Chief Commercial Officer	50,000	2022-02-24	1%
12	Chang William H	Director	35,000	2022-06-27	1%
13	Rauch Lee M.	Director	35,000	2022-06-27	1%
14	Rosebraugh Curtis	Director	35,000	2022-06-27	1%
15	Levin Adam	Director	35,000	2022-06-27	1%
16	Carrera Eric	Officer	30,000	2021-07-01	1%
17	Weinstein David L.	Director	25,000	2017-12-01	1%
18	Falcone Marc J.	Director	25,000	2017-12-01	1%
19	Rittvo Steven M	Director	25,000	2017-12-01	1%
20	Wright Richard Chester	Chief Business Officer	19,755	2021-07-02	1%